Carnegie Investment Counsel’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,190
| Closed | -$200K | – | 484 |
|
|
2023
Q3 | $200K | Sell |
7,190
-175
| -2% | -$4.88K | 0.01% | 473 |
|
|
2023
Q2 | $251K | Sell |
7,365
-190
| -3% | -$6.48K | 0.01% | 450 |
|
|
2023
Q1 | $227K | Sell |
7,555
-2,179
| -22% | -$65.5K | 0.01% | 473 |
|
|
2022
Q4 | $275K | Sell |
9,734
-205
| -2% | -$5.79K | 0.01% | 437 |
|
|
2022
Q3 | $327K | Sell |
9,939
-100
| -1% | -$3.29K | 0.02% | 392 |
|
|
2022
Q2 | $316K | Sell |
10,039
-1,209
| -11% | -$38.1K | 0.01% | 395 |
|
|
2022
Q1 | $517K | Sell |
11,248
-850
| -7% | -$39.1K | 0.02% | 343 |
|
|
2021
Q4 | $741K | Sell |
12,098
-11,624
| -49% | -$712K | 0.02% | 312 |
|
|
2021
Q3 | $1.77M | Buy |
23,722
+5,074
| +27% | +$379K | 0.07% | 194 |
|
|
2021
Q2 | $1.73M | Buy |
18,648
+2,727
| +17% | +$252K | 0.07% | 201 |
|
|
2021
Q1 | $1.41M | Buy |
15,921
+12,561
| +374% | +$1.11M | 0.06% | 213 |
|
|
2020
Q4 | $313K | Buy |
+3,360
| New | +$313K | 0.01% | 354 |
|